首页> 外国专利> compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, methods of prophylactic or therapeutic treatment of a condition where gk activation is desirable, prophylactic or therapeutic treatment of hyperglycemia or diabetes, and prevention of diabetes in a human demonstrating hyperglycemia. pre-diabetic or impaired glucose tolerance, and process for preparing the compound

compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, methods of prophylactic or therapeutic treatment of a condition where gk activation is desirable, prophylactic or therapeutic treatment of hyperglycemia or diabetes, and prevention of diabetes in a human demonstrating hyperglycemia. pre-diabetic or impaired glucose tolerance, and process for preparing the compound

机译:化合物或其药学上可接受的盐,药物组合物,需要gk激活的疾病的预防或治疗方法,高血糖或糖尿病的预防或治疗方法以及表现出高血糖的人的糖尿病预防。糖尿病前期或糖耐量受损,以及制备该化合物的方法

摘要

COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, PROPHYLATIC AND THERAPEUTIC TREATMENT METHODS WHERE ACTIVATION OF GK IS DESIRABLE, PROPHILABLE TREATMENT OR THERAPEUTIC DIAGNOSIS -DIABETIC OR TOLERANCE TO HARMFUL GLUCOSE, AND PROCESS FOR PREPARING THE COMPOUND Compounds of Formula (I) wherein R¬1¬ is a cycloalkylsulfonyl group, or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia. and diabetes.
机译:要求以相同的化合物,药物成分,药物组成,益生性和治疗性方法治疗GK的理想,可归因的治疗或治疗性诊断-糖尿病或耐受性强的化合物,其中化合物(葡萄糖) R 1-为环烷基磺酰基或其药学上可接受的盐,可用于预防和治疗高血糖症。和糖尿病。

著录项

  • 公开/公告号BRPI0514147A

    专利类型

  • 公开/公告日2008-05-27

    原文格式PDF

  • 申请/专利权人 PROSIDION LIMITED;

    申请/专利号BR2005PI14147

  • 申请日2005-08-09

  • 分类号C07D231/40;A61K31/415;A61K31/495;A61K31/4965;A61P3/10;C07C317/44;C07D237/20;C07D241/20;

  • 国家 BR

  • 入库时间 2022-08-21 20:08:44

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号